JAK redux: a second look at the regulation and role of JAKs in the heart
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAK redux: a second look at the regulation and role of JAKs in the heart
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 297, Issue 5, Pages H1545-H1556
Publisher
American Physiological Society
Online
2009-08-29
DOI
10.1152/ajpheart.00032.2009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Role of the Jak1 FERM and Kinase Domains in Cytokine Receptor Binding and in Stimulation-Dependent Jak Activation
- (2014) S. Haan et al. JOURNAL OF IMMUNOLOGY
- Cross-talk between calcineurin/NFAT and Jak/STAT signalling induces cardioprotective αB-crystallin gene expression in response to hypertrophic stimuli
- (2009) Irena Manukyan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Absence of JH2 domain mutation of the tyrosine kinase JAK2 in renal cell carcinomas
- (2008) Jianming Zhao et al. ACTA ONCOLOGICA
- Ser9 phosphorylation of mitochondrial GSK-3β is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis
- (2008) Katsuhiko Ohori et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Granulocyte Colony-Stimulating Factor Prevents Reperfusion Injury After Heart Preservation
- (2008) Takuya Higuchi et al. ANNALS OF THORACIC SURGERY
- Identification of Tyrosine 972 as a Novel Site of Jak2 Tyrosine Kinase Phosphorylation and Its Role in Jak2 Activation†
- (2008) Issam McDoom et al. BIOCHEMISTRY
- Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair
- (2008) H. Kobayashi et al. CARDIOVASCULAR RESEARCH
- JAK/STAT and PI3K/AKT Pathways Form a Mutual Transactivation Loop and Afford Resistance to Oxidative Stress-Induced Apoptosis in Cardiomyocytes
- (2008) Yanjie Lu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway
- (2008) Megumi Funakoshi-Tago et al. CELLULAR SIGNALLING
- LIMITATION OF INFARCT SIZE BY ERYTHROPOIETIN IS ASSOCIATED WITH TRANSLOCATION OF Akt TO THE MITOCHONDRIA AFTER REPERFUSION
- (2008) Hironori Kobayashi et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury
- (2008) Jarkko Piuhola et al. CLINICAL SCIENCE
- Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?
- (2008) Roberto Latini et al. HEART FAILURE REVIEWS
- Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart
- (2007) Lynn C. Huffman et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation
- (2007) N R Mudalagiri et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glycogen synthase kinases 3α and 3β in cardiac myocytes: Regulation and consequences of their inhibition
- (2007) Thomais Markou et al. CELLULAR SIGNALLING
- Making the heart resistant to infarction: how can we further decrease infarct size?
- (2007) Renaud Tissier Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation